These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 8564228)

  • 1. Pharmacological selectivity of the cloned human P2U-purinoceptor: potent activation by diadenosine tetraphosphate.
    Lazarowski ER; Watt WC; Stutts MJ; Boucher RC; Harden TK
    Br J Pharmacol; 1995 Sep; 116(1):1619-27. PubMed ID: 8564228
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Second messenger cascade specificity and pharmacological selectivity of the human P2Y1-purinoceptor.
    Schachter JB; Li Q; Boyer JL; Nicholas RA; Harden TK
    Br J Pharmacol; 1996 May; 118(1):167-73. PubMed ID: 8733591
    [TBL] [Abstract][Full Text] [Related]  

  • 3. P2-purinoceptor-mediated formation of inositol phosphates and intracellular Ca2+ transients in human coronary artery smooth muscle cells.
    Strøbaek D; Olesen SP; Christophersen P; Dissing S
    Br J Pharmacol; 1996 Aug; 118(7):1645-52. PubMed ID: 8842427
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PPADS and suramin as antagonists at cloned P2Y- and P2U-purinoceptors.
    Charlton SJ; Brown CA; Weisman GA; Turner JT; Erb L; Boarder MR
    Br J Pharmacol; 1996 Jun; 118(3):704-10. PubMed ID: 8762097
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacological and second messenger signalling selectivities of cloned P2Y receptors.
    Nicholas RA; Lazarowski ER; Watt WC; Li Q; Boyer J; Harden TK
    J Auton Pharmacol; 1996 Dec; 16(6):319-23. PubMed ID: 9131407
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enzymatic synthesis of UTP gamma S, a potent hydrolysis resistant agonist of P2U-purinoceptors.
    Lazarowski ER; Watt WC; Stutts MJ; Brown HA; Boucher RC; Harden TK
    Br J Pharmacol; 1996 Jan; 117(1):203-9. PubMed ID: 8825364
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Purinoceptor-stimulated phosphoinositide hydrolysis in Madin-Darby canine kidney (MDCK) cells.
    Yang CM; Tsai YJ; Pan SL; Tsai CT; Wu WB; Chiu CT; Luo SF; Ou JT
    Naunyn Schmiedebergs Arch Pharmacol; 1997 Jul; 356(1):1-7. PubMed ID: 9228183
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relative contribution of P2U- and P2Y-purinoceptors to endothelium-dependent vasodilatation in the golden hamster isolated mesenteric arterial bed.
    Ralevic V; Burnstock G
    Br J Pharmacol; 1996 Apr; 117(8):1797-802. PubMed ID: 8732294
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Co-existence of P2Y-and PPADS-insensitive P2U-purinoceptors in endothelial cells from adrenal medulla.
    Mateo J; Miras-Portugal MT; Castro E
    Br J Pharmacol; 1996 Nov; 119(6):1223-32. PubMed ID: 8937727
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of a cloned P2Y purinergic receptor that couples to phospholipase C.
    Filtz TM; Li Q; Boyer JL; Nicholas RA; Harden TK
    Mol Pharmacol; 1994 Jul; 46(1):8-14. PubMed ID: 8058061
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evidence for requirement of tyrosine phosphorylation in endothelial P2Y- and P2U- purinoceptor stimulation of prostacyclin release.
    Bowden A; Patel V; Brown C; Boarder MR
    Br J Pharmacol; 1995 Nov; 116(6):2563-8. PubMed ID: 8590971
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activity of diadenosine polyphosphates at P2Y receptors stably expressed in 1321N1 cells.
    Patel K; Barnes A; Camacho J; Paterson C; Boughtflower R; Cousens D; Marshall F
    Eur J Pharmacol; 2001 Nov; 430(2-3):203-10. PubMed ID: 11711032
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel P2-purinoceptor expressed by a subpopulation of astrocytes from the dorsal spinal cord of the rat.
    Ho C; Hicks J; Salter MW
    Br J Pharmacol; 1995 Dec; 116(7):2909-18. PubMed ID: 8680724
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Selectivity of diadenosine polyphosphates for rat P2X receptor subunits.
    Wildman SS; Brown SG; King BF; Burnstock G
    Eur J Pharmacol; 1999 Feb; 367(1):119-23. PubMed ID: 10082274
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The activation of P1- and P2-purinoceptors in the guinea-pig left atrium by diadenosine polyphosphates.
    Hoyle CH; Ziganshin AU; Pintor J; Burnstock G
    Br J Pharmacol; 1996 Jul; 118(5):1294-300. PubMed ID: 8818356
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Extracellular nucleotides act through P2U purinoceptors to elevate [Ca2+]i and enhance basic fibroblast growth factor-induced proliferation in sheep chondrocytes.
    Kaplan AD; Kilkenny DM; Hill DJ; Dixon SJ
    Endocrinology; 1996 Nov; 137(11):4757-66. PubMed ID: 8895344
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nucleotide-induced mucin release from primary hamster tracheal surface epithelial cells involves the P2u purinoceptor.
    Kim KC; Park HR; Shin CY; Akiyama T; Ko KH
    Eur Respir J; 1996 Mar; 9(3):542-8. PubMed ID: 8730017
    [TBL] [Abstract][Full Text] [Related]  

  • 18. P2U receptor is linked to cytosolic Ca2+ transient and release of vasorelaxing factor in bovine endothelial cells in situ.
    Miyagi Y; Kobayashi S; Nishimura J; Fukui M; Kanaide H
    J Physiol; 1996 May; 492 ( Pt 3)(Pt 3):751-61. PubMed ID: 8734987
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evidence for separate calcium-signaling P2T and P2U purinoceptors in human megakaryocytic Dami cells.
    Murgo AJ; Contrera JG; Sistare FD
    Blood; 1994 Mar; 83(5):1258-67. PubMed ID: 8118030
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of potent P2Y-purinoceptor agonists that are derivatives of adenosine 5'-monophosphate.
    Boyer JL; Siddiqi S; Fischer B; Romero-Avila T; Jacobson KA; Harden TK
    Br J Pharmacol; 1996 Aug; 118(8):1959-64. PubMed ID: 8864529
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.